TAVI | aortic stenosis, in all type of patients | vs standard therapy | stroke or TIA by 138% suggested All cause death by 38% suggested | Endpoint | TE [95% CI] | p val | I2 | n | k | |
---|
Death from any cause or major stroke | 0.66 [0.43 1.01] | p=1.00 | 0 | 358 | 1 | PARTNER, | major stroke | 2.00 [0.79 5.08] | p=1.00 | 0 | 358 | 1 | PARTNER, | stroke or TIA | 2.38 [1.01 5.58] | p=0.04 | 0 | 358 | 1 | PARTNER, | All cause death | 0.62 [0.40 0.95] | p=0.04 | 0 | 358 | 1 | PARTNER, |
Trial | Studied treatment | Control | Patients |
---|
PARTNER, 2010 | transcatheter aortic-valve
implantation (TAVI)with Edwards SAPIEN Transcatheter Heart Valve
| standard therapy | patients with severe aortic stenosis considered
not to be suitable candidates for surgery |
| |